RAR\#945;2 expression in myeloma cells plays a crucial role in disease progression and Effectiveness of ATRA treatment in myeloma

被引：0
|
作者：
Wang, Siqing
Tricot, Guido
Shi, Lei
Xiong, Wei
Zeng, Zhaoyang
Xu, Hongwei
Zangari, Maurizio
Barlogie, Bait
Shaughnessy, John, Jr.
Zhan, Fenghuang
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Univ Utah, Sch Med, Huntsman Canc Inst, Div Hematol BMT Myeloma, Salt Lake City, UT USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
742
引用
收藏
页数：2
相关论文
共 39 条
  • [31] Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
    Bai-Yan Wang
    Wan-Hong Zhao
    Yin-Xia Chen
    Xing-Mei Cao
    Yun Yang
    Yi-Lin Zhang
    Fang-Xia Wang
    Peng-Yu Zhang
    Bo Lei
    Liu-Fang Gu
    Jian-Li Wang
    Ju Bai
    Yan Xu
    Xu-Geng Wang
    Rui-Li Zhang
    Li-Li Wei
    Qiu-Chuan Zhuang
    Frank Fan
    Wang-Gang Zhang
    Ai-Li He
    Jie Liu
    Journal of Medical Case Reports, 16
  • [32] Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
    Wang, Bai-Yan
    Zhao, Wan-Hong
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Bai, Ju
    Xu, Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Zhuang, Qiu-Chuan
    Fan, Frank
    Zhang, Wang-Gang
    He, Ai-Li
    Liu, Jie
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [33] Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival (vol 91, pg 200, 2006)
    Vande Broek, I
    HAEMATOLOGICA, 2007, 92 (11) : 1584 - 1584
  • [34] Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival (vol 91, pg 200, 2006)
    Vande Broek, I
    Leleu, X.
    Schots, R.
    Facon, T.
    Vanderkerken, K.
    Van Camp, B.
    Van Riet, I
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 136 - 136
  • [35] Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3
    Fionda, Cinzia
    Malgarini, Giulia
    Soriani, Alessandra
    Zingoni, Alessandra
    Cecere, Francesca
    Iannitto, Maria Luisa
    Ricciardi, Maria Rosaria
    Federico, Vincenzo
    Petrucci, Maria Teresa
    Santoni, Angela
    Cippitelli, Marco
    JOURNAL OF IMMUNOLOGY, 2013, 190 (12): : 6662 - 6672
  • [36] Rapgef2, a guanine nucleotide exchange factor for Rapl small GTPases, plays a crucial role in adherence junction (AJ) formation in radial glial cells through ERK-mediated upregulation of the AJ-constituent protein expression
    Farag, Maged Ibrahim
    Yoshikawa, Yoko
    Maeta, Kazuhiro
    Kataoka, Tohru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 139 - 145
  • [37] Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
    Maria Pia Abruzzese
    Maria Teresa Bilotta
    Cinzia Fionda
    Alessandra Zingoni
    Alessandra Soriani
    Elisabetta Vulpis
    Cristiana Borrelli
    Beatrice Zitti
    Maria Teresa Petrucci
    Maria Rosaria Ricciardi
    Rosa Molfetta
    Rossella Paolini
    Angela Santoni
    Marco Cippitelli
    Journal of Hematology & Oncology, 9
  • [38] Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
    Abruzzese, Maria Pia
    Bilotta, Maria Teresa
    Fionda, Cinzia
    Zingoni, Alessandra
    Soriani, Alessandra
    Vulpis, Elisabetta
    Borrelli, Cristiana
    Zitti, Beatrice
    Petrucci, Maria Teresa
    Ricciardi, Maria Rosaria
    Molfetta, Rosa
    Paolini, Rossella
    Santoni, Angela
    Cippitelli, Marco
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [39] Pomalidomide (POM) plus low-dose dexamethasone (LoDEX) after lenalidomide (LEN)-based second-line (2L) treatment (Tx) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): Analysis of progression-free survival (PFS) by level of disease control.
    Siegel, David
    Schiller, Gary J.
    Song, Kevin W.
    Agajanian, Richy
    Stockerl-Goldstein, Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
1234